RET and familial pancreatic carcinoma: High levels of the GDNF receptor RET have been observed in pancreatic cancer cells, and genetic variation in RET has been linked to variation in proliferation and invasion in pancreatic cancer cells; because its levels of expression have a negative correlation with survival rate, RET has been proposed as a prognostic marker [37], [38].